An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare form of vasculitis that causes inflammation or swelling in the small and medium blood vessels. While it can cause damage to organs throughout the body, it most often affects the lungs.
The American Lung Association’s new EGPA Educational Campaign, provided with support from AstraZeneca and GlaxoSmithKline, strives to educate people living with EGPA, and their families and caregivers about this serious, but treatable disease. Here’s what they want you to know:
Symptoms are...
Reader Comments(0)